[1]
Rodríguez Quintosa, J., Ago, C.C., Sicras Mainar, A., Villoro, R. and Pérez-Román, I. 2022. Clinical and economic consequences of ozenoxacin vs. other topical antibiotics for the treatment of impetigo: a real-life study in Spain. Global and Regional Health Technology Assessment. 9, 1 (Oct. 2022), 133–137. DOI:https://doi.org/10.33393/grhta.2022.2439.